A Complex Adenovirus Vector That Delivers FASL–GFP with Combined Prostate-Specific and Tetracycline-Regulated Expression
Open Access
- 1 November 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 4 (5) , 416-426
- https://doi.org/10.1006/mthe.2001.0478
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Intracellular Fas Ligand Expression Causes Fas-Mediated Apoptosis in Human Prostate Cancer Cells Resistant to Monoclonal Antibody-Induced ApoptosisMolecular Therapy, 2000
- Adenoviral vector which delivers FasL–GFP fusion protein regulated by the tet-inducible expression systemGene Therapy, 2000
- Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the escherichia coli purine nucleoside phosphorylase geneHepatology, 2000
- Ganciclovir-mediated cell killing and bystander effect is enhanced in cells with two copies of the herpes simplex virus thymidine kinase geneCancer Gene Therapy, 2000
- Treatment of Experimental Glioma by Administration of Adenoviral Vectors Expressing Fas LigandHuman Gene Therapy, 1999
- Resistance to Fas (APO-1/CD95)-mediated apoptosis and expression of Fas ligand in esophageal cancer: the Fas counterattackDiseases of the Esophagus, 1999
- β-Galactosidase Gene Transfer to Human Malignant Glioma In Vivo Using Replication-Deficient Retroviruses and AdenovirusesHuman Gene Therapy, 1998
- Activation-induced death of mature T cells in the regulation of immune responsesCurrent Opinion in Immunology, 1995
- Cell-mediated cytotoxic mechanismsCurrent Opinion in Immunology, 1994
- A family of ligands for the TNF receptor superfamilyThe International Journal of Cell Cloning, 1994